Product
Tegaderm
1 clinical trial
2 indications
Indication
Pulmonary HypertensionIndication
PainClinical trial
A Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza® for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin®, in Pulmonary Arterial Hypertension PatientsStatus: Completed, Estimated PCD: 2012-07-01